These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 15315867

  • 1. Weight gain during insulin therapy in patients with type 2 diabetes mellitus.
    Heller S.
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S23-7. PubMed ID: 15315867
    [Abstract] [Full Text] [Related]

  • 2. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE.
    J Diabetes Complications; 2009 Sep; 23(2):143-52. PubMed ID: 18413192
    [Abstract] [Full Text] [Related]

  • 3. Insulin treatment and the problem of weight gain in type 2 diabetes.
    Carver C.
    Diabetes Educ; 2006 Sep; 32(6):910-7. PubMed ID: 17102158
    [Abstract] [Full Text] [Related]

  • 4. [Combination treatment with insulin and metformin in type 2 diabetes. Improves glycemic control and prevents weight gain].
    Hermann LS, Melander A.
    Lakartidningen; 1999 Dec 15; 96(50):5616-9. PubMed ID: 10643226
    [Abstract] [Full Text] [Related]

  • 5. Managing obesity and glycemic control in insulin-using patients: clinical relevance and practice recommendations.
    Gottesman I.
    Diabetes Res Clin Pract; 2004 Sep 15; 65 Suppl 1():S17-22. PubMed ID: 15315866
    [Abstract] [Full Text] [Related]

  • 6. [Development of body weight during antidiabetic treatment].
    Hamann A.
    Dtsch Med Wochenschr; 2006 Dec 15; 131 Suppl 8():S255-8. PubMed ID: 17139582
    [Abstract] [Full Text] [Related]

  • 7. Treatment of diabetes in patients with severe obesity.
    Scheen AJ.
    Biomed Pharmacother; 2000 Mar 15; 54(2):74-9. PubMed ID: 10759290
    [Abstract] [Full Text] [Related]

  • 8. Weight gain in type 2 diabetes mellitus--not all uphill.
    Cohen O, Norymberg C, Neumann E, Dekel H.
    Diabetes Res Clin Pract; 2008 Jan 15; 79(1):128-32. PubMed ID: 17720273
    [Abstract] [Full Text] [Related]

  • 9. Failure of insulin treatment in obese patients with non-insulin-dependent diabetes mellitus.
    Fassberg J, Toffler WL, Fields SA, Loriaux LD.
    J Fam Pract; 1993 Jul 15; 37(1):76-81. PubMed ID: 8345343
    [Abstract] [Full Text] [Related]

  • 10. The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss.
    Rowe R, Cowx M, Poole C, McEwan P, Morgan C, Walker M.
    Curr Med Res Opin; 2005 Nov 15; 21(11):1885-90. PubMed ID: 16307710
    [Abstract] [Full Text] [Related]

  • 11. The effects of pharmacologic agents for type 2 diabetes mellitus on body weight.
    Pi-Sunyer FX.
    Postgrad Med; 2008 Jul 15; 120(2):5-17. PubMed ID: 18654064
    [Abstract] [Full Text] [Related]

  • 12. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M, Orsini-Federici M.
    Diabetes Care; 2008 Feb 15; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [Abstract] [Full Text] [Related]

  • 13. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
    Spellman CW.
    J Am Osteopath Assoc; 2007 Jul 15; 107(7):260-9. PubMed ID: 17682113
    [Abstract] [Full Text] [Related]

  • 14. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Palumbo I, D'Angelo A, Cicero AF.
    Metabolism; 2009 Aug 15; 58(8):1059-66. PubMed ID: 19394976
    [Abstract] [Full Text] [Related]

  • 15. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
    Raskin P.
    Diabetes Obes Metab; 2008 Dec 15; 10(12):1167-77. PubMed ID: 18494804
    [Abstract] [Full Text] [Related]

  • 16. Pharmacotherapies for diabetes management: an update for the practicing clinician.
    Meneghini L, Hirsch IB.
    Semin Thorac Cardiovasc Surg; 2006 Dec 15; 18(4):379-89. PubMed ID: 17395035
    [Abstract] [Full Text] [Related]

  • 17. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
    Sheffield CA, Kane MP, Busch RS.
    Pharmacotherapy; 2007 Oct 15; 27(10):1449-55. PubMed ID: 17896900
    [Abstract] [Full Text] [Related]

  • 18. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L, Fanghänel G, Yamamoto J, Martínez-Rivas L, Campos-Franco E, Berber A.
    Clin Ther; 2004 Sep 15; 26(9):1427-35. PubMed ID: 15531005
    [Abstract] [Full Text] [Related]

  • 19. Does insulin detemir have a role in reducing risk of insulin-associated weight gain?
    Hermansen K, Davies M.
    Diabetes Obes Metab; 2007 May 15; 9(3):209-17. PubMed ID: 17391147
    [Abstract] [Full Text] [Related]

  • 20. Time to insulin in type-2 diabetes: high hurdles or Santiago way?
    Rotella CM, Pala L.
    Acta Diabetol; 2008 Jun 15; 45(2):67-74. PubMed ID: 18408882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.